Roche Holding AG (OTCMKTS:RHHBY) Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS decreased its holdings in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 33.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 91,239 shares of the company's stock after selling 45,684 shares during the quarter. Kornitzer Capital Management Inc. KS's holdings in Roche were worth $3,215,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Verity Asset Management Inc. increased its holdings in shares of Roche by 26.8% during the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock valued at $280,000 after acquiring an additional 1,697 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in shares of Roche by 0.9% during the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company's stock valued at $1,176,000 after acquiring an additional 305 shares in the last quarter. Brooklyn Investment Group increased its holdings in shares of Roche by 36.6% during the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company's stock valued at $48,000 after acquiring an additional 363 shares in the last quarter. Diversified Trust Co increased its holdings in shares of Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company's stock valued at $2,130,000 after acquiring an additional 711 shares in the last quarter. Finally, Bard Financial Services Inc. increased its holdings in shares of Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company's stock valued at $3,866,000 after acquiring an additional 30,350 shares in the last quarter.

Roche Trading Up 0.7 %

OTCMKTS:RHHBY traded up $0.27 during trading hours on Friday, reaching $41.42. The stock had a trading volume of 1,901,207 shares, compared to its average volume of 1,671,909. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $42.43. The company has a 50 day moving average price of $37.45 and a two-hundred day moving average price of $38.35.

Wall Street Analyst Weigh In

RHHBY has been the subject of several research analyst reports. Sanford C. Bernstein upgraded Roche to a "strong-buy" rating in a report on Thursday, January 30th. Morgan Stanley initiated coverage on Roche in a report on Wednesday, February 12th. They issued an "equal weight" rating for the company. Finally, UBS Group upgraded Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Roche presently has an average rating of "Hold".

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.